Attention Deficit Disorder (Add)

Shire PLC announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse. In this study, Vyvanse demonstrated significant improvement in ADHD symptoms as measured by the ADHD Rating Scale IV and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6-12 years. The post hoc analysis showed that patients demonstrated an improvement in emotional lability composite CPRS-RS...